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Abstract
Background: Neck pain of a mechanical nature is a common complaint seen by practitioners of manual medicine, 
who use a multitude of methods to treat the condition. It is not known, however, if any of these methods are superior 
in treatment effectiveness. This trial was stopped due to poor recruitment. The purposes of this report are (1) to 
describe the trial protocol, (2) to report on the data obtained from subjects who completed the study, (3) to discuss the 
problems we encountered in conducting this study.
Methods: A pragmatic randomised clinical trial was undertaken. Patients who met eligibility criteria were randomised 
into three groups. One group was treated using specific segmental high velocity low amplitude manipulation 
(diversified), another by specific segmental mobilisation, and a third group by the Activator instrument. All three 
groups were also treated for any myofascial distortions and given appropriate exercises and advice. Participants were 
treated six times over a three-week period or until they reported being pain free. The primary outcome measure for the 
study was Patient Global Impression of Change (PGIC); secondary outcome measures included the Short-Form Health 
Survey (SF-36v2), the neck Bournemouth Questionnaire, and the numerical rating scale for pain intensity. Participants 
also kept a diary of any pain medication taken and noted any perceived adverse effects of treatment. Outcomes were 
measured at four points: end of treatment, and 3, 6, and 12 months thereafter.
Results: Between January 2007 and March 2008, 123 patients were assessed for eligibility, of these 47 were considered 
eligible, of which 16 were allocated to manipulation, 16 to the Activator instrument and 15 to the mobilisation group. 
Comparison between the groups on the PGIC adjusted for baseline covariants did not show a significant difference for 
any of the endpoints. Within group analyses for change from baseline to the 12-month follow up for secondary 
outcomes were significant for all groups on the Bournemouth Questionnaire and for pain, while the mobilisation 
group had a significant improvement on the PCS and MCS subscales of the SF-36v2. Finally, there were no moderate, 
severe, or long-lasting adverse effects reported by any participant in any group.
Conclusions: Although the small sample size must be taken into consideration, it appears that all three methods of 
treating mechanical neck pain had a long-term benefit for subacute neck pain, without moderate or serious adverse 
events associated with any of the treatment methods. There were difficulties in recruiting subjects to this trial. This 
pragmatic trial should be repeated with a larger sample size.
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Background
Neck pain is a common disorder [1-6]. About 70% of
adults will experience neck pain during their lifetime, and
its point prevalence in the general population is around
22% [1,5,7-12]. After low back pain, neck pain is the most
common reason patients give for seeking chiropractic
care, and the second most common reason for the use of
spinal manipulation [13,14]. Treatment of neck pain is
costly in terms of utilisation of health care services, dis-
ability, compensation payments and lost work productiv-
ity [3,4,15,16]. Manipulation and mobilisation are both
commonly used by chiropractors, osteopaths and manip-
ulative physiotherapists to treat neck pain [17-21].
Among chiropractors the Activator instrument is also a
commonly used form of spinal manipulation [22-24].
The cause of neck pain is multifactorial and can be due
to musculoskeletal conditions, trauma, systemic condi-
tions, infections, inflammatory conditions or neoplasm
[1,4]. Usually, the underlying cause of neck pain is non-
specific and cannot be related to a particular pathology as
a cause of the presenting symptoms [1,4,25].
Numerous systematic reviews [1-3,5,15,26,27] have
assessed the evidence for the effectiveness of cervical
spine manipulation and mobilisation in the treatment of
non-specific neck pain. The results of these reviews for
effectiveness are inconclusive with failure to show any
one therapy as superior to any other. Five studies have
directly compared cervical manipulation and mobilisa-
tion with inconclusive results [8-10,28,29]. The quality of
these studies are, in the main, poor with inadequate sam-
ple sizes, inappropriate and non-validated outcome mea-
sures, inadequate follow-up and lack of a placebo
comparison group.
Bogduk [30] suggests that for neck pain there are no
data from any study determining the proportion of
patients that are pain free after manual therapy. More-
over, Peloso and Gross [31] suggest that due to the uncer-
tainty of the results obtained in the limited number of
studies of manipulation and mobilisation for neck pain,
further studies are needed to compare the different thera-
pies available for neck pain.
Very few clinical trials have studied manual therapy for
subacute neck pain [15,27,32,33], with the research
emphasis being placed on those subjects with complaints
lasting for longer than 6 months [34]. Further, there is a
dearth of evidence for the long-term effects of treatments
for subacute neck pain [35]. Evans et al. [36] also state
that there is a paucity of research evaluating the efficacy
of common treatments for acute and subacute neck pain
and, therefore, there is a lack of evidence to determine if
the treatment of subacute neck pain could reduce the
occurrence of chronic neck pain. The category of sub-
acute non-specific neck pain was selected for investiga-
tion to help fill the large gap in the literature regarding
effective treatments for this category of neck pain.
Harm from cervical manipulation is unknown, but esti-
mates range from one in 20,000 to five in 10,000,000 [2].
Ernst [37] states that manipulation of the cervical spine is
associated with serious complications, and even minor
adverse effects should be a contraindication to further
spinal manipulation. However, this impression was based
entirely on case reports. As part of the University of Cali-
fornia Los Angeles (UCLA) neck pain study, adverse reac-
tions to cervical manipulation and mobilisation were
determined [7]. Over 30% of the participants had reac-
tions to treatment. Increased neck pain and stiffness were
the most common symptoms; however, there were 212
adverse symptoms reported from chiropractic care.
Those randomised to manipulation were more likely than
those randomised to mobilisation to report adverse
effects within 24 hours of treatment. A recent paper in
the physiotherapy literature suggests that the benefits of
cervical manipulation have not been established, and the
associated risks of manipulation could be very serious
[19]. Di Fabio [38], based on a literature review, suggests
mobilisation should be used as an alternative to cervical
manipulation until more definitive information on the
benefits and risks of manipulation are known. However,
Cassidy et al. [39] in a recent study of stroke associated
with GP visits and chiropractor visits found the risk was
equal for patients consulting either practitioner. This sug-
gests that cervical manipulation may not be a cause of
stroke, but associated with a stroke in progress.
Due to difficulty in recruiting appropriate subjects to
the study we stopped the trial. The purposes of the study
were then to (1) describe the trial protocol, (2) report on
the results obtained for relative effectiveness of the three
types of manual therapy and their perceived adverse
effects, (3) discuss the problems we encountered in con-
ducting this study.
Methods
We conducted a pragmatic, randomised comparative trial
among patients with subacute (at least 4 weeks, but no
longer than 12 weeks duration) non-specific neck pain.
The study was conducted in the outpatient clinic of the
Anglo-European College of Chiropractic (AECC) during
two recruitment phases: January through July 2007 and
January through March 2008. The study received ethics
approval from AECC, and recruitment, assessments and
data analyses were conducted at AECC.
Participants
Participants were recruited through newspaper adver-
tisements using the local newspaper and regional com-
munity magazines of the greater Bournemouth
metropolitan area. All patients were examined by either
of the two chiropractic clinicians involved in the study
who made a clinical diagnosis of subacute non-specific
neck pain. Inclusion criteria for the study were age 18-64Gemmell and Miller Chiropractic & Osteopathy 2010, 18:20
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years; a new or recurrent episode of neck pain present for
more than 4 weeks, but no longer than 12 weeks; neck
pain that could extend to the shoulder region or upper
extremities, and be accompanied by headache, but neck
pain was more painful; the patient agreed not to take
medication or receive other treatment for neck pain dur-
ing the course of the study (paracetamol 500 mg 4 times a
day was allowed as rescue medication); and a baseline
pain level of at least 4 on the 11-point numerical rating
scale. Exclusion criteria were treatment with any of the
interventions during 6 months prior to recruitment to the
study; specific neck pain due to fracture, neoplasm, infec-
tion, inflammatory arthropathy, radiculopathy or myel-
opathy; factors contraindicating manipulation, such as
blood coagulation disorders, long-term use of corticos-
teroids, anticoagulant medications, history of neck sur-
gery, stroke or transient ischaemic attacks; plans to
relocate; inability to read or understand English; and
third-party liability or workers' compensation claims.
Randomisation
Randomisation was done on a block design using a com-
puter-generated programme, http://www.randomiza-
tion.com. Sequentially numbered sealed opaque
envelopes were prepared by a researcher not involved
with the study. During the trial the clinician opened the
envelope marked with the next consecutive number and
informed the patient about the treatment allocated. Par-
ticipants and clinicians were not masked to the type of
treatment.
Study protocol
This was a pragmatic trial and all participants received
oral reassurance about the usually benign course of non-
specific neck pain; trigger point pressure release to active
trigger points; postisometric relaxation stretching, exer-
cise advice and ergonomic advice. Two experienced chi-
ropractic clinicians delivered all study treatments. The
first clinician is a registered chiropractor with 30 years of
experience in general chiropractic practice. The second
clinician is also a registered chiropractor with 15 years of
experience in general chiropractic, and for the past six
years has been lead tutor for adjustive technique. Both
clinicians also have extensive experience in use of the
Activator instrument and in mobilisation, as well as
teaching these methods in an undergraduate chiropractic
programme.
We asked participants to record their medication use,
including all drugs taken for pain, in a specially designed
diary during the first three weeks after beginning treat-
ment. Participants were also asked to record perceived
prevalence and time of onset and duration for each
adverse effect in a diary during the first three weeks after
starting treatment. The categories of adverse effects were
similar to those used by Hurwitz et al. [7]: increased neck
pain, stiffness and soreness; radiating pain and discom-
fort; tiredness/fatigue; headache; dizziness, imbalance;
nausea, vomiting; blurred or impaired vision; ringing or
noises in the ear; arm or leg weakness; arm or leg numb-
ness; confusion, disorientation; depression, anxiety; and
any other adverse effect. The diaries on medication use
and adverse effects were collected by the clinician on the
last treatment visit or the participant posted these in a
stamped self-addressed envelope.
During the baseline visit, a clinician assessed the volun-
teer on the inclusion and exclusion criteria and informed
the person about the study. A complete history of neck
pain, associated conditions, red flags and prior treatment
were recorded. Physical examination followed a standard
format, including a neurological screen, looking for con-
traindications to manipulation and exclusions to partici-
pation. After this the clinician decided if radiographs
were necessary. None of the participants required x-rays.
Those who were eligible and agreed to participate were
asked to read the Information Form and sign the
Informed Consent Document. At this time the clinician
gave the participant all the baseline demographic and
outcome measures to complete. The clinician exited the
room to allow the participant to complete the forms with-
out interference.
Interventions
The treating clinician determined the level and side of the
manipulable lesions using his clinical judgement. Specific
considerations were given to pain and movement restric-
tion of individual spine segments from C1 to T4, localised
tenderness and presence of paraspinal muscle tenderness
and tautness. The same clinical assessment was used for
all three groups. Participants in each group received, at
no charge, two treatments per week for three weeks, and
were treated until symptom free or had received the max-
imum of six treatments. The duration of a single treat-
ment session was 10 to 15 minutes.
Manipulation
Spinal manipulation is a passive and rapid movement of a
joint beyond its active and passive limit of movement, but
remaining within the limit of the joint's anatomical integ-
rity. Participants received one to two dynamic thrusts,
applied with high velocity low amplitude force, directed
at one or more restricted upper thoracic or cervical spine
segments. This approach to manipulation is commonly
referred to as diversified technique.
Mobilisation
Mobilisation involves repetitive low-grade passive move-
ment with variation in amplitude. Participants received
low velocity low amplitude movements applied to one orGemmell and Miller Chiropractic & Osteopathy 2010, 18:20
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m o r e  r e s t r i c t e d  u p p e r  t h o r a c i c  o r  c e r v i c a l  s p i n e  s e g -
ments. The participant was supine and grade III poste-
rior-anterior and transverse oscillations were applied to
the articular pillar and spinous process.
The manner of delivery between manipulation and
mobilisation differed, with mobilisation having rhythmi-
cally applied smaller movements within a joint's physio-
logical range, whereas manipulation used a single
impulse of high velocity and low amplitude beyond the
physiological range of the joint.
Activator Instrument
An Activator IV instrument was applied with the patient
prone and with a setting of 1 for the Atlas and 2 for the
cervical and upper thoracic segments. Participants
received one thrust over the articular pillar in line with
the facet joint of the restricted segment. The analytical
procedure associated with Activator Methods was not
used. The force delivered with this instrument was high
velocity low amplitude within the physiological range of
the joint.
Outcome measures
All outcome measures were self-rated at entry and at the
end of treatment by participants filling out all outcome
measures while in the clinic, but without interference
from the clinician. The outcome measures were also
posted (with a stamped self-addressed return envelope)
to the participants at 3, 6 and 12 months from the end of
treatment.
Patient Global Impression of Change (PGIC) was the
primary outcome measure [40] and is determined by self-
assessment on a 7-point scale (1 = very much improved, 2
= much improved, 3 = minimally improved, 4 = no
change, 5 = minimally worse, 6 = much worse, and 7 =
very much worse). The PGIC is a single item extrapolated
from the Clinician's Global Impression of Change (CGIC)
tool [41]. It is used to assess response primarily in psy-
chopharmacological research [42]. The CGIC assessment
has been shown to be a valid outcome measure suitable
for routine use, reliable, and it is sensitive to change [43].
The PGIC has been used as the primary outcome in trials
of exercise and fibromyalgia [44], trials of the treatment
of pain syndromes have adopted the PGIC as a primary
outcome measure [45], and it has been suggested as use-
ful in manual therapy research [42]. While change in
mean group scores may be statistically significant, the
change may be of little use to the clinician and patient
[40,46-48]. Salaffi et al. [46] have determined that "much
improved" or "very much improved" means a clinically
important change for the patient. Therefore participants
selecting one of these options were considered to have
had a clinically meaningful improvement. The PGIC has
been extensively used by pain researchers as a standard
outcome and for comparison to other outcome measures
[49-52]. It is commonly used to assess patient's own
impressions of change [53,54]. It is intuitively logical
when considering statistical significance and clinical sig-
nificance [55]. Yalcin and Bump [56] assessed construct
validity of the PGIC compared to three independent mea-
sures of improvement and they found appropriate and
significant associations between the measures. Evangelou
et al. [57] analysed 63 different treatments in 240 trials
covering 18 conditions and found the PGIC assessments
of the effects of treatment are on average similar to those
of the CGIG with an OR = 0.98 (95% CI = 0.88 to 1.08).
Farrar et al. [58] also found a high correlation between
the CGIC and the PGIC, which they felt added credibility
to the validity of the PGIC. They went on to use the PGIC
as the "gold standard" to determine change in the numer-
ical rating scale for pain that is clinically significant.
Demyttenaere et al. [59] found patient rated global
improvement was significantly associated with the Symp-
tom Check List-90-Revised and the Beck Depression
I n v e n t o r y .  T h e y  c o n c l u d e d  t h a t  p a t i e n t s  w i t h  m a j o r
depressive disorder with at least moderate nonspecific
pain consider improvement globally by using pain,
depression, and anxiety in their overall impression of
improvement. Demyttenaere et al. [59] feel this global
judgement is more representative of the actually observed
and clinically relevant status or change. Therefore, the
primary endpoint with respect to relative effectiveness
was the proportion of participants marking "much
improved" or "very much improved" from baseline to the
12-month follow up. However, reliability in the form of
internal consistency and test-retest reliability is difficult
to determine for global impression of change scales as
internal consistency relates individual items of a ques-
tionnaire to the total score (global scales are composed of
a single question), and test-retest reliability would require
subjects to rate global change twice for the same problem
with the same period of improvement. Construct validity
may be supported by looking at the relationship between
physical outcomes and patient-reported outcomes [60].
A secondary outcome measure was the neck BQ devel-
oped by Bolton and Humphreys [25] for use in patients
with non-specific neck pain. This self-assessment ques-
tionnaire contains separate pre- and post-treatment sec-
tions. It uses 11-point numerical rating scales for pain,
functional and social activity, depression, anxiety, coping
ability and fear avoidance behaviours. The instrument
has been shown to be reliable, valid, responsive to change
and able to detect and quantify clinically significant
improvement [25,60-63]. All measurements were treated
as continuous variables and analysed for differences
between and within the groups using the total raw score.
Other secondary measures included the Short-FormGemmell and Miller Chiropractic & Osteopathy 2010, 18:20
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Health Survey (SF-36v2), and pain level taken from the
neck BQ. SF-36v2 component subscales of physical health
(PCS) and mental health (MCS) were treated as continu-
ous variables and used to compare differences between
and within the groups. This instrument is commonly
used in research and has been shown to be reliable and
valid [64-66]. The 11-point numerical rating scale for
pain is a valid and reliable measure of pain intensity [67-
70]. All measurements were treated as continuous vari-
ables and analysed for differences between and within the
groups.
Statistical analysis
There appeared to be some inequality at baseline so odds
ratios between the groups for the PGIC were adjusted for
the baseline covariants of age, gender, pain, quality of life,
and disability using binomial logistic regression. Within
group analyses from baseline to the 12-month endpoint
for each of the secondary outcome measures were con-
ducted using dependent t-tests. Differences between the
groups for each of the secondary outcome measures for
each of the follow up points were analysed by ANCOVA
adjusted for the baseline covariants [71]. Intention to
treat analysis was used, and the mean score for each
group on each outcome was inputted for missing values.
Statistical significance was set at P < 0.05. Statistical anal-
yses  w e r e  c onduct ed by  a  r esear c her  m as k ed t o gr oup
assignment and not involved in the conduct of the study
using SPSS software version 16.0.
Results
Between January 2007 and March 2008, 123 patients were
assessed for eligibility. Reasons for exclusion of 76
patients were neck pain for longer than 12 weeks (n = 45),
neck pain for longer than 12 weeks and pain <4 on the
NRS (n = 12), pain <4 on the NRS (n = 7), cervical radicu-
lopathy (n = 5), neck pain for less than 4 weeks (n = 2),
contraindications to manipulation (n = 2), pain <4 on the
NRS and nerve root lesion (n = 1), neck pain for longer
than 12 weeks and headache worse than neck pain (n =
1), and spinal manipulation in prior six months (n = 1). In
March of 2008 we had to terminate recruitment of
patients. At that time 47 participants had been included.
Of these 47 participants, 16 were allocated to manipula-
tion, 16 to the Activator instrument, and 15 to the mobil-
isation group (figure 1).
Baseline data are shown in Table 1. The figure shows
the number of participants who completed each of the
outcomes at each of the four follow up periods (end of
treatment, 3 months, 6 months and 12 months from the
end of treatment). During the three-week treatment
phase, three participants dropped out of the Activator
instrument group, two from the mobilisation group, and
one form the manipulation group. We were only able to
ascertain the reason for withdrawal from treatment of
one participant (manipulation group) and that was to
care for a seriously ill spouse.
Primary outcome
Treatment was considered successful if the participant
marked "improved" or "much improved" on the PGIC at
the 12-month endpoint. In the Activator group 5 of 10
participants (50%) considered themselves to be improved,
for the manipulation group this was 8 of 11 (73%), and for
the mobilisation group 10 of 13 considered themselves
improved (77%). Table 2 shows the adjusted odds ratios
for the difference between groups on the PGIC. No sig-
nificant differences were found between the groups for
any of the follow up points.
Secondary outcomes
Comparisons between the groups on the neck BQ from
baseline to each of the follow up points are shown in
Table 3. There were no significant differences between
the groups at any of the follow up points. All groups had a
decrease in raw scores from baseline through to the 12-
month follow up. Disability decreased by 13 points over
12 months in the Activator instrument group, 18 points
in the manipulation group, and 15 points in the mobilisa-
tion group. A reduction of at least 13 points is considered
a clinically significant improvement.
Table 4 shows the comparisons between the groups on
neck pain from baseline to each of the follow up points.
There were no significant differences between the groups
at any of the follow up points. All groups had a decrease
in pain from baseline to the 12-month follow up point.
Pain decreased by 3 points in the Activator group, 4
points in the manipulation group, and 3 points in the
m o b i l i s a t i o n  g r o u p .  A  r e d u c t i o n  i n  p a i n  o f  a t  l e a s t  2
points is considered a clinically meaningful improve-
ment.
Table 5 shows comparisons between the groups on the
MCS subscale of the SF-36v2 from baseline to each follow
up point. There were no significant differences between
the groups at any of the follow up points. All groups had
small improvements in the MCS from baseline to the 12-
month end point. The Activator group had an improve-
ment of 4 points, manipulation 3 points, and mobilisation
7 points.
Comparisons between the groups on the PCS subscale
of the SF-36v2 from baseline to each follow up point are
shown in table 6. There were no significant differences
between the groups at any of the follow up points. All
groups had small improvements in the PCS from baseline
to the 12-month endpoint. The Activator group had an
improvement of 2 points, manipulation 5 points, and
mobilisation 8 points.Gemmell and Miller Chiropractic & Osteopathy 2010, 18:20
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Figure 1 Flow chart for patient recruitment and follow up. For each follow up point the number of participants completing each of the outcome 
measures is indicated.
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Adverse events
Fifteen subjects reported adverse events with manual
therapy, seven with Activator, four with manipulation and
four with mobilisation. All instances of side effects were
minor and resolved within 1-3 days. Table 7 shows the
type and number of adverse effects reported by each
group.
Use of rescue medication
Ten subjects reported use of rescue medication, five with
Activator, three with manipulation, and two with mobili-
sation (table 8).
Within group analysis
Table 9 shows the mean within group change from base-
line to the 12-month endpoint. On the outcomes of the
BQ and pain all groups had a significant improvement.
The mobilisation group was the only group to show a sig-
nificant improvement on the PCS and MCS subscales of
the SF-36v2.
Discussion
The trial was not designed to evaluate the individual
components of the treatments, but to compare the rela-
tive effect of adding a different form of spinal dysfunction
correction to a package of care used by most chiroprac-
tors and osteopaths. This package of care consisting of
TrP therapy, exercise advice and ergonomic advice may
have its own beneficial effects [72-82], and we wanted to
determine the benefit of adding each of the forms of
manipulation used. We had difficulty in recruiting
participants and stopped the trial before its expected
completion.
Table 1: Baseline variables of the three interventions (Activator, Manipulation and Mobilisation)
Variable Activator Manipulation Mobilisation
Mean age (SD) 46.8 (11.8) 46.9 (9.1) 43.8 (13.0)
Mean BMI (SD) 25.6 (5.4) 27.6 (7.0) 24.7 (3.5)
Mean BQ raw score (SD) 30.2 (10.9) 32.2 (9.6) 25.6 (10.6)
Females % 81 69 87
Mean NRS for pain (SD) 6.7 (1.5) 6.0 (1.3) 4.9 (1.3)
Mean SF-36 PCS (SD) 40.6 (6.5) 45.3 (8.5) 44.5 (6.0)
Mean SF-36 MCS (SD) 49.2 (12.0) 47.2 (9.6) 48.0 (10.2)
Table 2: Comparison between treatment groups for Patient Global Impression of Change adjusted for baseline covariants
Time Act v Man Act v Mob Man v Mob
OR 95% CI OR 95% CI OR 95% CI
End 0 0 to 0 0 0 to 0 1.2 0.78 to 19.58
3 1.4 0.13 to 17.56 2.6 0.06 to 112.81 5.8 0 to 0
6 1.5 0.13 to 17.56 13.8 0.63 to 299.67 2.8 0.06 to 122.80
12 3.8 0.39 to 37.18 3.3 0.27 to 40.61 1.2 0.09 to 15.96
End = end of treatment; 3 = 3 month follow up; 6 = 6 month follow up; 12 = 12 month follow up
OR = adjusted odds ratios
95% CI = 95% confidence interval
Act = Activator instrument, Man = manipulation, Mob = mobilisationGemmell and Miller Chiropractic & Osteopathy 2010, 18:20
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Key findings
On the primary outcome of patient global impression of
improvement, there were no significant differences
between the groups at any of the follow up points. For the
secondary outcomes of disability (BQ) and pain based on
improvement from baseline to the 12-month endpoint all
groups had a statistically significant improvement. How-
ever, only the mobilisation group showed a statistically
significant improvement from baseline to 12 months on
quality of life measures (SF-36v2). This suggests that all
groups exhibited long-term improvement without one
being superior to the other. However, due to the small
sample size the result could be explained by chance and
must be interpreted with caution. Further research is
necessary with larger sample sizes to determine if the
result of equality between the groups is a true effect or
simply due to chance.
If further studies also show that equal results may be
achieved using either Activator, diversified or mobilisa-
tion, perhaps our understanding of the putative lesion we
treat may need to be revised. Currently, most osteopaths
and chiropractors would suggest that manipulation
restores normal joint play to a dysfunctional spine joint
[83-91]. We now know that the surrounding fascia of a
spine joint contains many more sensory receptors than
the spine joint itself [87-91]. Recent research suggests
that mechanical stimulation of an acupuncture needle
and manual therapy procedures affect the network of
fibroblasts via a process called mechanotransduction that
can affect gene expression within the cell explaining the
long-term effects achieved with these therapies [91-96].
This would also help explain how different methods of
mobilisation from reflex methods to HVLA manipulation
seem to have equal effects [5,10,15,26,27,29,97].
Table 3: Comparison between the treatment groups for the Bournemouth Questionnaire adjusted for baseline covariants
Time Act v Man Act v Mob Man v Mob
Mean 95% CI Mean 95% CI Mean 95% CI
End 0.19 -10.63 to 11.03 -0.77 -14.42 to 12.95 -0.94 -13.56 to 11.69
3 1.57 -12.07 to 15.20 4.35 -15.68 to 24.38 2.78 -15.54 to 21.09
6 8.69 -4.46 to 21.83 8.57 -7.82 to 24.96 -0.86 -15.54 to 15.31
12 6.54 -9.03 to 22.10 5.68 -12.33 to 23.69 -0.86 -17.28 to 15.59
Mean = mean difference
End = end of treatment; 3 = 3 months; 6 = 6 months; 12 = 12 months
95% CI = 95% confidence interval
Act = Activator instrument, Man = manipulation, Mob = mobilisation
Table 4: Comparison between the treatment groups for pain adjusted for baseline covariants
Time Act v Man Act v Mob Man v Mob
Mean 95% CI Mean 95% CI Mean 95% CI
End 0.81 -1.83 to 1.99 0.24 -2.19 to 2.62 0.13 -2.09 to 2.36
3 0.39 -1.58 to 2.35 1.33 -1.55 to 4.22 0.95 -1.69 to 3.58
6 1.96 -0.34 to 4.26 1.61 -1.26 to 4.48 -0.35 -3.05 to 2.35
12 1.72 -1.17 to 4.62 1.30 -2.05 to 4.65 -0.42 -3.47 to 2.63
Mean = mean difference
End = end of treatment; 3 = 3 months; 6 = 6 months; 12 = 12 months
95% CI = 95% confidence interval
Act = Activator instrument, Man = manipulation, Mob = mobilisationGemmell and Miller Chiropractic & Osteopathy 2010, 18:20
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Adverse effects
A recent large cohort study [98] did not find any severe
adverse effects from chiropractic manipulation. The only
symptoms perceived by participants in the current study
as being adverse were minor and short-lived. Surprisingly
the Activator instrument group had a higher proportion
of these adverse effects as compared to manipulation, and
mobilisation had a higher proportion of adverse effects as
compared to manipulation. The reason why the Activator
instrument was perceived by participants as being possi-
bly harmful may be due to the fact we did not go into
great detail about each treatment, but gave enough infor-
mation for the participant to make an informed decision
about participating. Further, the instrument has a
mechanical, surgical appearance and the 'clicking' noise
may have added to this concern. Also, patients' naïve to
chiropractic care were enrolled in the study. Therefore, it
is possible a nocebo effect could have occurred.
W e  h a v e  n o  e x p l a n a t i o n  a s  t o  w h y  m o b i l i s a t i o n  w as
perceived as more likely to cause an adverse effect com-
pared to manipulation other than to suggest that while
manipulation involved a quick thrust, segmental mobili-
sation was delivered to a specific point and mobilised
over a longer period of time. If the point being mobilised
was tender, then the participant may have viewed this as
harmful.
A greater proportion of those in the Activator instru-
ment group had to resort to rescue medication as com-
pared to those in the manipulation and mobilisation
groups. This may be explained by a significantly higher
level of pain in the Activator instrument group at base-
line.
Table 5: Comparison between the groups for the Mental Component Summary of the SF-36v2 adjusted for baseline 
covariants
Time Act v Man Act v Mob Man v Mob
Mean 95% CI Mean 95% CI Mean 95% CI
End -0.81 -8.75 to 7.14 5.81 -4.34 to 15.85 6.62 -2.66 to 15.89
3 -1.98 -10.57 to 6.61 -0.66 -13.28 to 11.96 1.32 -10.23 to 12.86
6 -1.28 -10.47 to 7.89 0.89 -10.55 to 12.34 2.18 -8.59 to 12.95
12 0.42 -7.74 to 8.59 -1.75 -11.19 to 7.69 -21.17 -10.78 to 6.44
Mean = mean difference
End = end of treatment; 3 = 3 months; 6 = 6 months; 12 = 12 months
95% CI = 95% confidence interval
Act = Activator instrument, Man = manipulation, Mob = mobilisation
Table 6: Comparison between the groups for the Physical Component Summary of the SF-36v2 adjusted for baseline 
covariants
Time Act v Man Act v Mob Man v Mob
Mean 95% CI Mean 95% CI Mean 95% CI
End 2.39 -3.79 to 8.57 1.67 -6.14 to 9.47 -0.73 -7.93 to 6.48
3 1.56 -4.01 to 7.12 -2.56 -10.73 to 5.61 -4.11 -11.59 to 3.36
6 -2.72 -10.04 to 4.59 -3.68 -12.81 to 5.46 -0.95 -9.55 to 7.64
12 -4.41 -12.48 to 3.66 -4.53 -13.87 to 4.80 -0.12 -8.64 to 8.39
Mean = mean difference
End = end of treatment; 3 = 3 months; 6 = 6 months; 12 = 12 months
95% CI = 95% confidence interval
Act = Activator instrument, Man = manipulation, Mob = mobilisationGemmell and Miller Chiropractic & Osteopathy 2010, 18:20
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Difficulties in recruitment
The major problem we had with recruitment was overes-
timating the effect of advertising and the lack of adequate
time for screening and treating patients in the study. We
limited advertising to the major newspaper and maga-
zines of the Bournemouth metropolitan area. Perhaps
increasing coverage to radio and billboards would have
helped in recruitment. Initially advertising was so suc-
cessful that we had a waiting list of patients to be
screened and we did not have enough time allocated to
see the patients. Due to the stringent eligibility criteria,
particularly the necessity for the subject to have sub-
a c u t e  n e c k  p a i n ,  b y  t h e  t i m e  w e  w e r e  a b l e  t o  s e e  t h e
patient he/she was no longer able to meet the eligibility
criteria. Both clinicians teach full-time on the undergrad-
uate and postgraduate programmes and when we were
able to devote more time to this study the advertising was
not drawing the numbers as it had done initially. The
Bournemouth area has a catchment of about 300,000
people and this may have been a limiting factor as com-
pared to a large metropolitan area such as London. We
then reached a point where we were no longer able to
advertise further, due to a lack of funds, and had to stop
the trial.
Our problems with recruitment were similar to those
noted by Vernon et al. [99] in their study of tension-type
headache. We considered a multicentre study may be a
way in the future to obtain larger sample sizes; however,
Vernon et al. [99] noted a problem with this approach in
that it produced variation in delivery of trial protocols.
Perhaps if this factor can be controlled a multicentre
study could be a way of increasing numbers in a trial.
While we gave free care to all participants to increase
participation, perhaps remuneration for participating
could have increased the number of those willing to be
involved. However, this would affect external validity of
the study as those being paid to participate may be funda-
mentally different to those who pay for their care.
Upon reflection we feel a dedicated research centre
with full-time practitioner-researchers would be one way
of solving the perennial problem of recruitment, assum-
ing grants are available for such a venture. This would be
particularly appropriate for studying the relative effec-
tiveness of the various therapeutic interventions used in
manual therapy and would allow generalisability to stan-
dard chiropractic and osteopathic care.
Comparison with other studies
Our finding of mobilisation causing more adverse effects
than manipulation is in contrast to the study of neck pain
by Hurwitz et al. [7] in which mobilisation was shown to
have fewer adverse effects. As mentioned above, this
could be due to the nocebo effect in participants' naïve to
the different methods of chiropractic treatment. It is diffi-
cult to directly compare our study to this study as we
included subacute neck pain patients while the study by
Hurwtiz et al. included both subacute and chronic neck
pain patients. Similar to the study by Hurwitz et al. we
found the most commonly occurring adverse effect to be
neck pain, stiffness/soreness. In our study 27% of those in
the manipulation group had this symptom (28% in the
Hurwitz et al. study), and 15% in the mobilisation group
had this symptom (22% in the Hurwitz et al. study). In
comparison 54% of those in the Activator instrument
group had the same adverse symptom.
Previous randomised clinical trials have directly com-
pared manipulation, mobilisation and the Activator
instrument [96]; however, only one previous study has
assessed the long-term effectiveness of manipulation ver-
sus mobilisation [10]. An evaluation of the effect of man-
ual therapies on neck pain was investigated by Dziedzic et
al [100], and they found no additional effect after six
Table 7: Adverse effects
Adverse symptom Activator Manipulation Mobilisation
Mildly increased neck 
pain
74 2
Mild radiating pain 5 2 1
Mild arm weakness 1 0 0
Mild arm numbness 1 0 0
Mild headache 3 3 4
Mild fatigue 3 3 0
Mild dizziness 1 1 1
Mild muscle 
twitching
01 0
Values represent the number of subjects in each group experiencing 
the symptom. All symptoms were short-lived (1-3 days).
Table 8: Number of participants in each group using rescue 
medication
Group Rescue Medication No Rescue Medication
Activator 58
Manipulation 31 2
Mobilisation 21 1Gemmell and Miller Chiropractic & Osteopathy 2010, 18:20
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m o n t h s  w h e n  a d d i n g  m a n i p u l a t i o n  t o  e x e r c i s e  a n d
advice. This is different to our study where we found a
significant difference from baseline to 12 months within
all groups.
To our knowledge, this present study is the first ran-
domised clinical trial to compare the long-term effective-
ness of manipulation, mobilisation and the Activator
instrument for subacute non-specific neck pain. Our
results agree with the study of Hurwitz et al. in that
manipulation and mobilisation basically give comparable
clinical results. One difference in the studies is that the
study by Hurwitz et al. had a 6-month follow up while we
had a 12-month follow-up.
Limitations
Our study has several limitations. Firstly, the participants
could not be masked to treatment, and neither were the
clinicians masked to group assignment. We tried to avoid
bias by having all outcome measures self-assessment
instruments that participants did not complete in front of
the clinicians. Secondly, by not having a placebo control
group the results obtained may be explained by non-spe-
cific effects due to the attention given to the participants
in each of the groups. Further, it is possible that the clini-
cal improvement observed could be due to the myofascial
therapy that all subjects received and the manipulative
therapies were irrelevant to the outcome. Thirdly, we
cannot exclude the possibility that patients with specific
causes of neck pain may have participated in the study.
However , we feel this is unlikely as we required a firm
diagnosis of non-specific neck pain, followed by strict
inclusion criteria. Those with specific causes of neck pain
are unlikely to change the results of the study, as we
would expect that they were equally distributed over the
three arms. Finally, the disproportionate dropout rate for
the Activator group compared to the other groups could
also be a limitation of the study.
As we had to end recruitment early, we conducted a
power analysis post hoc. Based on the PGIC comparing
the Activator instrument group and the manipulation
group, the PS programme version 2.1.31 http://bio-
stat.mc.vanderbilt.edu/ was used to calculate power
achieved. At a power of 0.80 and alpha of 0.05, 18 subjects
per group were needed. The limited sample size we had
gave us a power of 0.75. Therefore, the study was under-
powered and subject to Type II error. Due to this limita-
tion, the study has to be considered a pilot study.
The pragmatic design of this study we feel helps in
external validity. None of the eligible patients refused to
participate, we had few drop-outs, we used manipulative
techniques commonly used in chiropractic practice, and
had the participants engage in exercises, gave them myo-
fascial therapy and clinical advice allowing generalisabil-
ity to most modern chiropractic practices. However, the
study was underpowered making it difficult to be genera-
lised. Further factors affecting generalisability were our
stringent inclusion criteria and the fact all subjects were
recruited through advertising in local newspapers. These
volunteers also received care free of charge. It is possible
that such volunteers, receiving care for free are not the
s a m e  a s  p a t i e n t s  w h o  g e n e r a l l y  s e e k  c h i r o p r a c t i c  o r
osteopathic care.
Conclusion
Our trial was stopped early due to an inability to recruit
participants. However, our limited sample suggested a
significant long-term improvement in subacute non-spe-
cific neck pain for all groups. Based on the comparable
outcomes and low risk of adverse effects, chiropractors
Table 9: Within group change from baseline to the 12-month end point
Outcome Activator Mean (SD) 95% CI Manipulation Mean (SD) 95% CI Mobilisation Mean (SD) 95% CI
BQ 13 (12.3) 5.49 to 20.36* 18 (15.9) 8.27 to 28.57* 15 (13.9) 7.71 to 23.09*
NRS 3 (2.3) 1.93 to 4.69* 4 (2.7) 1.79 to 5.20* 3 (2.4) 1.60 to 4.27*
PCS 2 (4.8) -5.14 to 0.68 5 (8.5) -10.65 to 0.18 8 (6.2) -11.08 to -4.26*
MCS 4 (8.9) -9.79 to 1.04 3 (5.8) -6.53 to 0.88 7 (8.9) -11.62 to -1.74*
BQ = Bournemouth Questionnaire
NRS = numerical rating scale for pain
PCS = physical component summary of the SF-36v2
MCS = mental component summary of the SF-36v2
Mean = mean improvement
SD = standard deviation
* = significant at p < 0.05Gemmell and Miller Chiropractic & Osteopathy 2010, 18:20
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and osteopaths may obtain equally effective results by
treating neck pain patients with manipulation, the Acti-
vator instrument, or mobilisation. However, the result
must be treated with caution due to the small sample size
and, this interesting finding needs to be confirmed in
larger trials.
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